13007-37-9

Basic information

• Product Name: METHYL-2,3,4-TRI-O-ACETYL-BETA-D-XYLOPYRANOSIDE
• Synonyms: METHYL-2,3,4-TRI-O-ACETYL-BETA-D-XYLOPYRANOSIDE;METHYL-2,3,4-TRI-O-ACETYL-SS-D-XYLOPYRANOSIDE
• CAS NO: 13007-37-9
• Molecular Formula: C₁₂H₁₈O₈
• Molecular Weight: 290.26652
• Mol File: 13007-37-9.mol
• Article Data: 5

Chemical Properties

• Melting Point: 115 °C(Solv: water (7732-18-5))
• Boiling Point: 332.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.24±0.1 g/cm3(Predicted)
• CAS DataBase Reference: METHYL-2,3,4-TRI-O-ACETYL-BETA-D-XYLOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-2,3,4-TRI-O-ACETYL-BETA-D-XYLOPYRANOSIDE(13007-37-9)
• EPA Substance Registry System: METHYL-2,3,4-TRI-O-ACETYL-BETA-D-XYLOPYRANOSIDE(13007-37-9)

Safety Data

• Hazardous Substances Data: 13007-37-9(Hazardous Substances Data)

Upstream product

• 108-24-7 acetic anhydride 
• 53448-52-5 methyl β-L-xylopyranoside 
• 612-05-5 methyl-β-D-xylopyranoside 
• 91-09-8 methyl α-L-xylopyranoside 
• 95851-48-2 C₄₂H₆₈O₁₂ 
• 91-09-8 methyl α,β-L-xyloside 
• 67-56-1 methanol 
• 4049-33-6 tetra-O-acetyl-β-D-xylopyranose 
• 19186-38-0 O¹,O³,O⁴-Triacetyl-α-D-xylopyranose 
• 74-88-4 methyl iodide 

Downstream Products

• 612-05-5 methyl-β-D-xylopyranoside 
• 74162-08-6 methyl 2,4-di-O-acetyl-β-D-xylopyranoside 
• 41897-35-2 methyl 2-mono-O-acetyl-β-D-xylopyranoside 
• 77217-82-4 methyl 3,4-di-O-acetyl-β-D-xylopyranoside 

Relevant articles and documents

ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE

Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.

Synthesis of acylated methyl β-D-xylopyranosides and their enzymic deacylations by rabbit serum esterases

Selective pivaloylations of methyl β-D-xylopyranoside have been studied under various reaction conditions. Partially pivaloylated products were submitted to additional acetylations. The structures were established by 1H NMR spectroscopy. Representatives of acylated methyl β-D-xylopyranosides (acyl being pivaloyl, acetyl, or a combination of both) were submitted to hydrolysis catalyzed by rabbit serum and esterases isolated from rabbit serum.

Studies on the constituents of Momordica cochinchinensis SPRENG. II. Isolation and characterization of the root saponins, momordins I, II and III

-